(43 days)
The North American Scientific, Inc Brachytherapy Preloaded Needle Kit is indicated for interstitial implantation of select localized tumors with low to medium radiosensitivity. They are used primarily for treatment for tumors such as those in the head, neck, lung, pancreas, breast, cervix and prostate and unresectable tumors or for residual disease after excision of the primary tumor. Preloaded implants are used with or at the completion of other treatment modalities such as external beam radiation therapy or chemotherapy.
Not Found
I apologize, but this document is a 510(k) clearance letter from the FDA for a medical device called the "nStrand Implantation Kit." It confirms that the device is substantially equivalent to legally marketed predicate devices.
This document specifies the indications for use of the device but does NOT contain any information regarding:
- Acceptance criteria or reported device performance. The letter is an administrative approval, not a performance study report.
- Study details such as sample sizes, data provenance, expert qualifications, adjudication methods, MRMC studies, standalone performance, types of ground truth, or training set information.
Therefore, I cannot provide the requested information based on the content of this document. To answer your request, I would need a clinical study report or a performance evaluation document for the nStrand Implantation Kit.
§ 892.5730 Radionuclide brachytherapy source.
(a)
Identification. A radionuclide brachytherapy source is a device that consists of a radionuclide which may be enclosed in a sealed container made of gold, titanium, stainless steel, or platinum and intended for medical purposes to be placed onto a body surface or into a body cavity or tissue as a source of nuclear radiation for therapy.(b)
Classification. Class II (special controls). A prostate seeding kit intended for use with a radionuclide brachytherapy source only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.